Blockade of orexin receptors reduces blood pressure in spontaneously hypertensive rats (SHRs) but not in normotensive Wistar-Kyoto (WKY) rats, suggesting that upregulation of orexin signalling underlies the hypertensive phenotype of the SHR. However, it is not known what causes this upregulation. r What is the main finding and its importance?
Introduction
The spontaneously hypertensive rat (SHR) has been used for the last 50 years as an animal model of essential hypertension (Okamoto & Aoki, 1963) . It is now well established that the origin of hypertension in the SHR is central and linked to sympathetic nerve activity (SNA; Korner, 2007; Fisher & Paton, 2012; McBryde et al. 2013) . Spontaneously hypertensive rats have exaggerated SNA starting from an early age, in fact before hypertension develops (Adams et al. 1989; Korner et al. 1993; Zicha & Kunes, 1999) . The reason for this elevated SNA is unclear, but recent studies by Li et al. (2013) and Lee et al. (2013) suggest that the hypothalamic neuropeptide orexin (otherwise known as hypocretin) could play an important role. The study by Li et al. (2013) showed that systemic administration of the dual orexin receptor antagonist almorexant markedly reduced basal blood pressure in the SHR but not in its normotensive relative, the Wistar-Kyoto (WKY) rat. The effect was observed during both wakefulness and sleep.
Orexin plays a critical role in the regulation of arousal. It is necessary for the maintenance of wakefulness as well as for the expression of motivated behaviour, from reward seeking to responses to stress (Harris & Aston-Jones, 2006; Furlong et al. 2009; de Lecea, 2010; Sakurai & Mieda, 2011) . Remarkably, orexin originates from a restricted group of neurons located in the dorsal tuberal part of the hypothalamus, in an area that corresponds to the classic hypothalamic defense region (Hilton, 1982; Peyron et al. 1998; Nambu et al. 1999) . Orexin neurons project throughout the brain from cortex to spinal cord including central autonomic areas, such as the pressor area of the rostral ventrolateral medulla and the sympathetic preganglionic neurons of the thoracic cord (Carrive, 2013) . Thus, injections of orexin in the rostral ventrolateral medulla or the subarachnoid space of the thoracic cord or in the cerebral ventricles raise SNA and evoke pressor and tachycardic responses (Shirasaka et al. 1999; Chen et al. 2000; Antunes et al. 2001; Shahid et al. 2011 Shahid et al. , 2012 Carrive, 2013) . These cardiovascular responses are one component of the co-ordinated effect of orexin on arousal.
The results obtained by Li et al. (2013) indicate that orexin signalling is upregulated in the SHR. It is not clear whether the upregulation is on the presynaptic or postsynaptic side, but the study by Lee et al. (2013) suggests the former. Indeed, these authors found no difference between SHRs and WKY rats in the protein expression of the orexin receptors Ox1R and Ox2R in selected autonomic regions, except in the rostral ventrolateral medulla, where a downregulation of Ox2R was found. Given that Ox2R activation causes pressor and tachycardic effects (Huang et al. 2010; Shahid et al. 2012; Lee et al. 2013) , a downregulation of Ox2R in the SHR strongly suggests a compensatory response to an exaggerated release of orexin in the rostral ventrolateral medulla. This could be due to a greater activity of orexin neurons or to a greater number of orexin neurons or both. Here, we test the possibility that the SHR phenotype is linked to a greater number of orexin neurons. For control animals, we used two strains of normotensive rats, WKY and Wistar.
Methods

Ethical approval
All the procedures were approved by the Animal Ethics Committee of the University of New South Wales and complied with the rules and guidelines on animal experimentation in Australia.
Animals and experimental protocol
The main experiment was performed on 12 SHRs, 11 WKY rats and five Wistar rats purchased from the Animal Resource Center, Perth, WA, Australia (SHR/NCrlArc, WKY/NCrlArc and ArcCRL:Wi). They were all males, with ages ranging from 6 to 16 weeks (150-500 g). The animals were housed in groups of three, with ad libitum food and water, on a normal 12 h-12 h light-dark cycle (lights off at 19.00 h). The experiment was run in 12 rounds. In each round, tissue was processed from one SHR and at least one normotensive rat (one SHR and one WKY rat, seven rounds; one SHR and one Wistar rat, one round; and one SHR, one WKY rat and one Wistar rat, four rounds) to ensure that the immunohistochemical processing was the same for the SHR and the normotensive rats. A 13th round of three more rats (one of each strain, identical to the others) was used for an additional experiment, bringing the total number of animals to 13 SHRs, 12 WKY rats and six Wistar rats.
Perfusion and immunohistochemical processing
The animals were killed with an overdose of pentobarbitone (120 mg kg −1 , I.P.) and perfused transcardially with 4% paraformaldehyde after a brief saline wash. The brains were removed, postfixed for 2 h, and dropped into 20% sucrose for cryoprotection. Two days later, they were cut with a cryostat into six series of 40-µm-thick transverse sections. Equidistant series 1 and 4 were processed for immunohistochemical detection of orexin. The other series were kept as spares. After a series of washes (30 min each) in 50% ethanol, 50% ethanol with 1% hydrogen peroxide, and 5% normal horse serum, the sections were incubated with a primary anti-orexin A mouse antibody (1:3000 dilution, MAB763; R&D Systems, Minneapolis, MN, USA) at 4°C for 48 h. The specificity of this antibody has been verified in prepro-orexin knock-out mice (see Supplemental data in Zhu et al. 2007) . The sections were then washed and re-incubated first with a biotinylated donkey anti-mouse secondary antibody (1:1000 dilution, 715-065-150; Jackson Immunoresearch, Westgrove, PA, USA) at 4°C overnight and then with Xtravidin peroxidase (1:1000 dilution; Sigma) for 2.5 h. Orexin A was finally revealed with a nickel-enhanced 3,3 -diaminobenzidine tetrahydrochloride reaction. The sections were mounted onto gelatin-coated slides, dried and coverslipped with mounting medium.
Histological analysis
Orexin-positive neurons of both reacted series of sections were plotted and counted by an experimenter who was blinded to the rat strain, using the StereoInvestigator system (MBF Bioscience, Williston, VT, USA) connected to an Olympus BX-51 U microscope. In each of the two reacted series, the three hemisections with the highest number of orexin-positive neurons were selected for analysis (ie a total of six hemisections per brain). The hypothalamus was first divided into a medial and a lateral zone (MHyp and LHyp) through a vertical line passing through the centre of the fornix (Fig. 1) . The MHyp and LHyp were then further divided. A second vertical line was drawn two-thirds of the distance from the edge of the third ventricle to the centre of the fornix, separating the dorsomedial hypothalamus (DMH) from the medial part of the perifornical hypothalamus (MPeF; Fig. 1 ). The width of the MPeF was reported lateral to the centre of the fornix to define the lateral part of the PeF (LPeF). The rest of the lateral zone is referred to as the lateral hypothalamic area (LHA). The number of neurons in each of the zones was finally averaged across the six selected hemisections of each rat. Group averages were calculated for each strain and analysed with one-way or two-way ANOVAs, followed by Bonferroni post hoc analyses. The analysis was done with Prism 6 (GraphPad Software, Inc., La Jolla, CA, USA), with statistical significance set at P < 0.05.
Sagittal reconstruction of the orexin neuron population
An additional round was run, in which three brains (one SHR, one Wistar rat and one WKY rat, aged 15, 15 and 13 weeks, respectively) were cut sagittally to compare the full anteroposterior extent of the orexin neuron population. The sagittal sections were 40 µm thick and collected into three series. One series was processed for immunohistochemical detection of orexin as described above (see 'Perfusion and immunohistochemical processing'). The stained sections were photographed and imported into Adobe Photoshop CS5 as separate L. Clifford and others layers in a single document. The sections were then carefully realigned according to fibre bundles, blood vessels and fiducial marks placed before cutting. Next, the overlaid layers were blended together using the Darken blending mode of Photoshop, which made the sections semi-transparent and brought up the darkly stained orexin neurons (see Fig. 4Aa -c). The layers were also imported into Adobe Illustrator CS5, where the neurons were plotted, layer by layer. The sagittal projection of these plots was then divided into 40-µm-wide vertical slabs equivalent to a transverse section ( Fig. 4Ba-c) . Finally, the number of orexin neurons in each virtual transverse section was plotted to determine the anteroposterior profile of the orexin group in each of the three brains ( Fig. 4C -E).
Results
Orexin neurons are found in the dorsal part of the tuberal hypothalamus. They form a group centred on the perifornical hypothalamus (PeF), which extends from the dorsomedial nucleus of the hypothalamus (DMH) to the LHA (Fig. 1 ). There was no striking difference in the appearance, number and distribution of orexin neurons between SHRs, WKY rats and Wistar rats, at least at first glance ( Fig. 1 ). However, on close inspection and after looking at more sections, one got the impression that the SHR had a greater number of orexin neurons. This was confirmed by counting orexin neurons in the six best labelled hemisections of each brain (sections 120 µm apart). As shown in Fig. 2A , SHRs had on average more neurons than Wistar rats, which had more neurons than WKY rats (195 ± 6, 180 ± 8 and 155 ± 6 orexin neurons per hemisection, respectively). An ANOVA confirmed a strain effect [F(2,25) = 12.16, P < 0.0001]. Bonferonni post hoc analysis also confirmed that the difference between SHRs and WKY rats was statistically significant (P < 0.001); however, the differences between SHRs and Wistar rats and between Wistar and WKY rats were not [although the difference between Wistar and WKY was significant with a non-corrected post hoc test (Fisher's LSD), P = 0.025].
It has been proposed that medial and lateral orexin neurons have different functions (Harris & Aston-Jones, 2006) ; therefore, we refined our analysis by dividing the hypothalamus into a medial and a lateral zone relative to the fornix (MHyp and LHyp, respectively; Figs 1 and 2B). As can be seen in Fig. 2B , there were more orexin neurons medial to the fornix in all three strains. Interesting new strain differences were also apparent within each zone. A two-way ANOVA confirmed main laterality and strain effects [F(1,25) = 291 and F(2,25) = 12.59, respectively, both P < 0.001]. It also revealed an interaction between strain and laterality, suggesting that there were different strain patterns between medial and lateral hypothalamus [F(2,25) = 8.98, P = 0.001]. Thus, while SHRs still had more orexin neurons than WKY rats in both MHyp and LHyp, they differed relative to Wistar rats. In MHyp, SHRs had more orexin neurons than Wistar and WKY rats, which were equivalent (126 ± 4 versus 104 ± 5 and 106 ± 5, respectively; Fig. 2B ), whereas in LHyp, SHRs and Wistar rats were equivalent and both had more neurons than WKY rats (69 ± 2 and 76 ± 4 versus 50 ± 3, respectively; Fig. 2B ). Post hoc analysis confirmed that these differences were statistically significant (P < 0.01 in MHyp and P < 0.001 in LHyp).
The DMH is well known for its role in autonomic control (Dimicco et al. 2002; Dampney et al. 2008) ; therefore, we thought of further dividing MHyp to separate the DMH from the medial part of the PeF (MPeF). Likewise, LHyp was divided into a lateral PeF (LPeF) and the LHA (Figs 1 and 2C Values are shown as means ± SEM. * P < 0.05; * * P < 0.01; * * * P < 0.001, Bonferroni post hoc analysis. Abbreviations are the same as in Fig. 1 .
above, a two-way ANOVA revealed significant main strain and laterality effects as well as an interaction between strain and laterality [F(2,100) = 23.4, F(3,100) = 144.4 and F(6,100) = 4.8, respectively, all P < 0.001]. As can be seen in Fig. 2C , the strain pattern of the MHyp was in both the DMH and MPeF. Spontaneously hypertensive rats had significantly more orexin neurons in DMH and MPeF than both Wistar and WKY rats (DMH, 53 ± 3 versus 43 ± 3 and 46 ± 3, respectively, P < 0.05; MPeF, 72 ± 2 versus 61 ± 3 and 60 ± 2, respectively, P < 0.01).
The effect was more significant in the MPeF, which was also the area with the greatest number of orexin neurons. The strain pattern of the LHyP was also in the LPeF, where SHRs and Wistar rats were the same and both had more neurons than WKY rats (48 ± 2 and 46 ± 3 versus 32 ± 2, respectively, P < 0.01). The pattern was not as obvious in the LHA, where only Wistar rats had significantly more neurons than WKY rats (21 ± 2 and 30 ± 1 versus 18 ± 1, respectively; P = 0.01 between Wistar and WKY rats).
The age of the rats ranged between 6 and 16 weeks. Age was evenly distributed within the three strains, with no significant difference between them [9.7 ± 0.6, 11.4 ± 2.2 and 9.3 ± 0.7 weeks for SHRs, Wistar and WKY rats, respectively; F(2,25) = 1.02; P = 0.37]. To find out whether there was a relationship between age and the number of orexin neurons in each of the strains, regression analyses were performed for the total number of orexin neurons and for the medial and lateral zones (Hyp, MHyp and Lhyp; Fig. 3 ). As can be seen, there was no apparent relationship between these variables. No significant correlation between age and orexin neuron numbers could be found in any of these three zones for the three strains separately or together (r 2 < 0.32; P > 0.07).
Finally, an additional three brains (one SHR, one Wistar rat and one WKY rat, aged 15, 15 and 13 weeks, respectively) were cut sagittally to compare the anteroposterior distribution of the orexin neurons in the three strains. Sections of the hypothalamus on one side were photographed, realigned and the neurons counted at a 40 µm interval as shown in Fig. 4 . The central graph (Fig. 4C) shows the number of orexin neurons per 40 µm interval along the anteroposterior axis in the three brains. As can be seen, the SHR brain had more orexin neuron than the Wistar and WKY brains, and these extra neurons were located medial to the fornix ( Fig. 4D  and E) , as revealed by the analysis on transverse sections above. Figure 4C also shows that the anteroposterior extent of the orexin neuron population was the same in the three brains (ß1600 µm), although the population appeared more spread out along the dorsoventral axis in the SHR and WKY rat than in the Wistar rat (Fig. 4Aa-c and Ba-c). The extra orexin neurons of the SHR were in the middle third (anteroposterior) of the orexin group approximately between 2.5 and 3.0 mm behind bregma.
Discussion
The main finding of this study is that SHRs have more orexin-expressing neurons than normotensive WKY and Wistar rats but only in the medial hypothalamus, not in the lateral hypothalamus. Thus, the upregulation of orexin signalling in the SHR and its contribution to elevated resting blood pressure may be due, at least in part, to a greater number of orexin neurons medial to the fornix. 
Figure 4. Anteroposterior distribution of orexin neurons in the brains of an SHR, a Wistar rat and a WKY rat
Orexin was revealed in sagittal sections, which were then realigned. The sections were 40 µm thick, and every third section was collected (i.e. they were 120 µm apart). Aa-c shows reconstructions from individual photomicrographs of these sections after they were rendered semi-transparent to reveal the full extent of the orexin neuron population on one side. The rendering was done using the Darken blending mode in Photoshop. Anterior is on the left and dorsal is at the top. Ba-c shows plots of the neurons from the reconstructed stacks of Aa-c. The vertical grey bars are 40 µm wide and correspond to transverse sections as described in Fig. 1 . They are 120 µm apart, which corresponds to the sampling used for the quantitative studies depicted in Fig. 2 . C-E shows the number of orexin neurons per virtual 40 µm transverse section in the three brains. C shows the entire population (Hyp), while D and E show only those neurons that are medial or lateral to the fornix, respectively (MHyp and LHyp). Note that the anteroposterior extent of the orexin neuron population is the same in the three brains and that the number of neurons medial to the fornix in the middle of the orexin group is greater in the SHR than in the Wistar and WKY rats. Abbreviations: A, anterior; D, dorsal; f, fornix; Hyp, hypothalamus; LHyp, lateral part of the hypothalamus; MHyp, medial part of the hypothalamus; mt, mammillothalamic tract; opt, optic tract; P, posterior; and V, ventral. Orexin neurons in spontaneously hypertensive rats
Methodological considerations
The sagittal reconstructions show that the anteroposterior extent of the orexin neuron population was practically the same in the SHRs, Wistar and WKY rats. The distribution was bell shaped, with the peak in the centre. With the transverse sections, the analysis was limited to the six hemisections with the heaviest labelling in two of six series. At a thickness of 40 µm, these six hemisections would have covered a minimal distance of 400 µm and would have been around the peak in the middle third of the group where the differences between strains were the most obvious. The rest of the discussion is based on the quantitative analysis of these transverse sections. Although blood pressure was not recorded in the rats of the present experiment, other experiments in our laboratory using adult rats from the same supplier indicate that daytime mean arterial pressure at rest is ß130-140 mmHg in SHRs and 90-100 mmHg in WKY and Wistar rats.
Medial orexin neurons are linked to the blood pressure phenotype
Overall, SHRs had more orexin neurons than normotensive WKY rats; however, the total number of orexin neurons did not match the blood pressure phenotype when normotensive Wistar rats were added to the comparison. To be more specific, the total number of orexin neurons in normotensive Wistar rats was closer to that in hypertensive SHRs than to normotensive WKY rats (SHR > Wistar >> WKY). A different picture emerged when medial and lateral orexin neurons were considered separately. In the medial hypothalamus, there was in fact a very good match between the number of orexin neurons and the blood pressure phenotype (SHR >> Wistar = WKY), while in the lateral hypothalamus it was a different pattern (SHR = Wistar >> WKY). This would suggest that medial orexin neurons are linked to the blood pressure phenotype and that more medial orexin neurons lead to higher blood pressure.
This link between medial orexin neurons and blood pressure is consistent with the well-known role of the medial hypothalamus in cardiovascular control (Dimicco et al. 2002; Dampney et al. 2008; Fontes et al. 2011) and with reports that pressor effects are stronger when evoked chemically from the dorsomedial and perifornical hypothalamus than from the lateral hypothalamus (Allen & Cechetto, 1992; Cerri & Morrison, 2005; McDowall et al. 2006) . It is also supported by previous work from our group showing that almorexant significantly reduces the pressor responses evoked by disinhibition of the perifornical hypothalamus (Iigaya et al. 2012) or by stressors that preferentially evoke Fos expression in medial orexin neurons (Furlong et al. 2009 ).
Medial orexin neurons are linked to stress and arousal
There is also a link between medial orexin neurons and stress. Thus, it has been proposed that medial but not lateral orexin neurons drive arousal, homeostatic and stress responses (Scammell & Saper, 2005; Harris & Aston-Jones, 2006 ). This idea is based in large part on Fos studies showing that arousal associated with the circadian rhythm and hyperarousal associated with amphetamine, exercise, certain forms of stress or extended amygdala disinhibition preferentially activate medial orexin neurons (Estabrooke et al. 2001; Nixon & Smale, 2004; Furlong et al. 2009; Johnson et al. 2009; Zhang et al. 2009 ). Tracing studies also show that medial orexin neurons receive inputs that are consistent with these functions (Yoshida et al. 2006) .
If medial orexin neurons are linked to stress and arousal, then an increase in their number, as seen in the SHR, should lead to enhanced arousal and stress responses in this strain. That is the case. Compared with WKY and normotensive Sprague-Dawley rats, SHRs display greater pressor responses to sensory stimuli and stressors such as the open field test, handling, air jet and restraint (Casto & Printz, 1990; van den Buuse et al. 2001; McDougall et al. 2005) . Furthermore, compared with Wistar and WKY rats, SHRs are slower to habituate to a new context even after repeated exposure (Paré, 1989b; Sagvolden et al. 1993) and are worse at discriminating sensory stimuli in a two-component schedule of re-enforcement (Sagvolden et al. 1993) . As a result of these behavioural traits, the SHR is considered by some to be a good animal model of attention-deficit hyperactivity disorder (Sagvolden, 2000) . All these observations converge towards one conclusion; that medial orexin neurons control not only blood pressure but also stress responses and that an increase in their number will lead to hyperactivity, impulsivity, exaggerated stress responses and a higher resting blood pressure, basically recapitulating the SHR phenotype.
Lateral orexin neurons are linked to reward-seeking behaviour
Our results showed that lateral orexin neurons are not linked to the blood pressure phenotype (SHR = Wistar >> WKY). They are not linked to stress or arousal either, but they are linked to another type of motivated behaviour, one that is related to appetitive rather than aversive stimuli, i.e. reward-seeking behaviour (Scammell & Saper, 2005; Harris & Aston-Jones, 2006) . This is also based in part on Fos experiments showing that lateral but not medial orexin neurons are activated by reward-seeking behaviour such as choosing a context associated with cocaine, morphine and food. The same is observed after inhibition of the shell of the accumbens nucleus, which is known to induce powerful motivational L. Clifford and others states (Baldo et al. 2004; Harris et al. 2005) . Lateral orexin neurons also receive preferential input from the shell of the nucleus accumbens and are reciprocally connected to the ventral tegmental area, structures that are implicated in reward Yoshida et al. 2006) .
If lateral orexin neurons are linked to reward seeking, then a decrease in their number, as seen in the WKY rat, should also lead to decreased reward-seeking behaviour and possibly anhedonia in this strain. That is the case. Wistar-Kyoto rats are considered by some to be a good animal model of depression (Paré, 1994) . Thus, compared with Wistar rats and SHRs, they display little exploratory behaviour in the open field, take longer to bury a new object, give up faster in the forced swim test, are more sensitive to learned helplessness and show behavioural inhibition in a passive avoidance test (Paré, 1989a (Paré, ,b, 1993 (Paré, , 1994 . Furthermore, WKY rats have more rapid eye movement sleep than Wistar rats, which is considered a hallmark of depression (Dugovic et al. 2000) . Finally, it has already been shown that orexin is downregulated in WKY rats. Thus, WKY rats have 18% fewer neurons than Wistar rats (total number; Allard et al. 2004) , which is very similar to the 15% difference we observed in the present study (total number, 155 versus 180, respectively). Wistar-Kyoto rats also show a 20-30% reduction of hypothalamic orexin A immunoreactivity and prepro-orexin mRNA levels compared with Wistar rats (Taheri et al. 2001 ). The present results show that this downregulation of orexin in WKY rats comes from lateral orexin neurons, not medial orexin neurons. Thus, lateral orexin neurons are linked to the regulation of reward-seeking behaviour, and a reduction in their number may lead to depression (Allard et al. 2004; Nollet & Leman, 2013) . Spontaneously hypertensive rats, which have the same number of lateral orexin neurons as Wistar rats, are normal with respect to these behaviours.
Orexin in the development of essential hypertension
A greater number of medial hypothalamic neurons expressing orexin can explain the upregulation of orexin signalling and the hypertensive phenotype of the SHR. Medial orexin neurons in SHRs could also be more active than in normotensive animals, but this does not necessarily have to be the case if their number is already increased. Thus, an increase in medial orexin neurons will increase orexin release and orexin drive downstream, including the medullary and spinal relays that control sympathetic outflow to the heart and blood vessels, hence the depressor effect of almorexant at rest , and the compensatory downregulation of the Ox2R in the pressor region of the rostral ventrolateral medulla (Lee et al. 2013) .
It is well known that hypertension in SHRs develops after 5 weeks of age and continues to increase until 20 weeks of age (Adams et al. 1989; Korner et al. 1993; Zicha & Kunes, 1999) . In the present experiment, the ages of SHRs and WKY rats varied between 6 and 12 weeks, which is the period when orexin neurons reach their maximum in Wistar rats (Sawai et al. 2010) . However, there was no correlation between age and number of orexin neurons in the SHR population. It was the same number of orexin neurons at 6 and 12 weeks. This supports the idea that the development of hypertension is due to a cumulative effect over time of the increased sympathetic drive on the vasculature (Korner et al. 1993; Korner, 2007) . This increased sympathetic drive is already present in the juvenile prehypertensive SHR (Adams et al. 1989; Korner et al. 1993; Cabassi et al. 1998 ) and can be detected 2 weeks after birth (Simms et al. 2009 ). It may be that these young, prehypertensive SHRs already have more orexin neurons than their normotensive WKY or Wistar relatives and that this is one reason for the development of hypertension in this strain.
Importantly, there is also evidence for the reverse, i.e. that stress can increase orexin expression and the number of orexin neurons. Thus, it has been shown that the amount of prepro-orexin mRNA in the hypothalamus doubles for up to 2 weeks after a single footshock session (Chen et al. 2014) . The number of orexin neurons can also be increased by 20% after 1 week of housing in stressful conditions (Allard et al. 2007) , and hypertension induced by daily footshock for 2 weeks doubles the number of orexin neurons (Xiao et al. 2012) . These changes, which are not trivial, indicate that orexin expression can be upregulated by stress in an otherwise healthy, normotensive individual. The reason for the upregulation in this case is not genetic, as in the SHR, but environmental, yet the outcome is the same, an increase in sympathetic activity, which will lead over time to a chronic state of hypertension.
Perspectives
The SHR has been a model of neurogenic hypertension for more than 50 years. These animals have elevated sympathetic nerve activity and are hyperactive and impulsive, two traits that can be linked to an upregulation of orexin signalling. As a hypothalamic peptide, orexin is perfectly placed to link hyperarousal, stress and neurogenic hypertension, be it innate as in the SHR or acquired upon exposure to repeated stress. The present study is consistent with the findings of Li et al. (2013) and Lee et al. (2013) on the contribution of orexin to hypertension in the SHR by showing that there is an increase in orexin neurons in this strain. More importantly, it shows that this might be the work of a subpopulation of orexin neurons located in the medial part of the perifornical hypothalamus. Systemic administration of orexin receptor antagonists already appears to be a promising approach to treat some forms of hypertension, but it may have unwanted effects on other orexin functions. Targeting those medial orexin neurons would be preferable. We need a better understanding of how these neurons produce and release orexin.
